MoonLake discloses up to $500M in financing; OSR’s deal with innovation fund 

MoonLake Immunotherapeutics gets financing worth up to $500M: The company will get $75 million upfront from Hercules Capital. MoonLake, which went public in 2022, had about $448 million in cash before ...